Cosentyxhcp.com
Top hcp sites |
- Title
- IL-17A Antagonist for PsO, PsA, & AS - COSENTYX (secukinumab)
- Meta Description
- Learn about COSENTYX (secukinumab), the first fully human IL-17A antagonist approved for plaque psoriasis, psoriatic arthritis, andankylosing spondylitis.
- Meta Keywords
- Technologies in use
- Bootstrap, reCaptcha, jQuery, moment, Font Awesome
Cache-Control | public,must-revalida |
X-Powered-By | Salesforce.com ApexP |
P3P | CP="CUR OTR STA" |
Expires | Tue, 27 Feb 2018 18: |
Last-Modified | Tue, 27 Feb 2018 18: |
Content-Type | text/html; charset=U |
Vary | Accept-Encoding |
Content-Encoding | gzip |
Transfer-Encoding | chunked |